Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ohno

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Microbiology and Immunology|June 13, 2003
Autologous cancer vaccine: a novel formulationTadao Ohno
Cancer Letters|December 4, 2003
Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma modelLan Huang, Tadao Ohno
Clinical Case Reports|June 12, 2023
Successful monotherapy with autologous formalin-fixed tumor vaccine for a Stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatmentKatsuhiko Fukuda, Tadao Ohno
World Journal of Surgical Oncology|July 14, 2012
Autologous formalin-fixed tumor vaccine suppressed re-recurrence of HCV-related hepatocellular carcinoma following 29 unsuccessful treatments with extensive conventional therapy: a case reportToshio Inui, Tadao Ohno
World Journal of Surgical Oncology|June 6, 2013
Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case reportFumito Kuranishi, Tadao Ohno
Clinical Case Reports|October 29, 2015
Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel-carboplatin therapy responded to autologous formalin-fixed tumor vaccineJui-Tung Chen, Tadao Ohno
Advances in Experimental Medicine and Biology|May 29, 2012
Adoptive cell transfer therapy for malignant gliomasEiichi Ishikawa, Shingo Takano, Tadao Ohno, et al.
Human Cell|September 17, 2004
A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assayHideki Harada, Kaoru Saijo, Isamu Ishiwata, et al.
Journal of Neuro-Oncology|September 1, 2005
Targeted tumor cell death induced by autologous tumor-specific T lymphocyte recognition of wild-type p53-derived peptidesHideo Tsurushima, Yoshihiko Yoshii, Kam W Leong, et al.
Acta Biomaterialia|April 10, 2022
Synergistic anti-tumor efficacy of a hollow mesoporous silica-based cancer vaccine and an immune checkpoint inhibitor at the local siteXiupeng Wang, Xia Li, Atsuo Ito, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Microbiology and Immunology|June 13, 2003
Autologous cancer vaccine: a novel formulationTadao Ohno
Cancer Letters|December 4, 2003
Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma modelLan Huang, Tadao Ohno
Clinical Case Reports|June 12, 2023
Successful monotherapy with autologous formalin-fixed tumor vaccine for a Stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatmentKatsuhiko Fukuda, Tadao Ohno
World Journal of Surgical Oncology|July 14, 2012
Autologous formalin-fixed tumor vaccine suppressed re-recurrence of HCV-related hepatocellular carcinoma following 29 unsuccessful treatments with extensive conventional therapy: a case reportToshio Inui, Tadao Ohno
World Journal of Surgical Oncology|June 6, 2013
Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case reportFumito Kuranishi, Tadao Ohno
Clinical Case Reports|October 29, 2015
Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel-carboplatin therapy responded to autologous formalin-fixed tumor vaccineJui-Tung Chen, Tadao Ohno
Advances in Experimental Medicine and Biology|May 29, 2012
Adoptive cell transfer therapy for malignant gliomasEiichi Ishikawa, Shingo Takano, Tadao Ohno, et al.
Human Cell|September 17, 2004
A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assayHideki Harada, Kaoru Saijo, Isamu Ishiwata, et al.
Journal of Neuro-Oncology|September 1, 2005
Targeted tumor cell death induced by autologous tumor-specific T lymphocyte recognition of wild-type p53-derived peptidesHideo Tsurushima, Yoshihiko Yoshii, Kam W Leong, et al.
Acta Biomaterialia|April 10, 2022
Synergistic anti-tumor efficacy of a hollow mesoporous silica-based cancer vaccine and an immune checkpoint inhibitor at the local siteXiupeng Wang, Xia Li, Atsuo Ito, et al.
Pageof 6